Page last updated: 2024-08-25

brusatol and Head and Neck Neoplasms

brusatol has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, KS; Lee, JH; Lin, ZX; Mohan, CD; Rangappa, KS; Rangappa, S; Sethi, G	1

Other Studies

1 other study(ies) available for brusatol and Head and Neck Neoplasms

Article	Year
Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma. Biomolecules, 2019, 09-30, Volume: 9, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Quassins; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor	2019

Article

Year

Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma.

Biomolecules, 2019, 09-30, Volume: 9, Issue:10

Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Quassins; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; STAT3 Transcription Factor

2019